hemeonclinx Medical News

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Oncology

For Practicing
Oncologists

Conferences

Jobs

Newsletters

My Library

Topics in
Oncology

Alternative Therapies

Anemia/Polycythemia

BMT/SCT

Basic Science/Genetics

Bone/Cartilage

Breast

Carcinogenesis

Coagulation/Bleeding Dz

Colorectal Cancer/Polyps

Dermatologic Oncology

Diagnostics/Radiology

Economics of Medicine

Endocrine Oncology

GI Oncology

Gynecologic Oncology

Head and Neck

Hepatobiliary/Pancreas

Leukemia/Lymphoma

Lung/Thoracic Oncology

Myeloproliferative Dz

Neurologic Oncology

Pain/Palliative Care

Pediatric Heme/Oncology

Pharmacology/Therapy

Popular Press

Renal/Urologic

Side Effects

Soft Tissue/Sarcoma

Transfusion Medicine

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

For Practicing Oncologists

Improving Your Bottom Line: Mid Year Analysis Vital to Practice
Owen Dahl, Owen Dahl Consulting

FDA Update: Immune Response Robustness Correlates with Survival in Brain Cancer Vaccine Trial
Tracy Hampton, PhD, MDLinx Oncology

See all

Oncology, Hematology, cancer journals, cancer articles, oncology conference, cancer medical journals, medical news, cancer, breast cancer, cancer articles, drugs,leukemia, lymphoma, blood, articles, medical diagnosis, chemotherapy, multiple myeloma,interferon, bone marrow, hodgkin's disease, bone marrow transplant, cancer treatment, aml, cml, chronic lymphocytic leukemia, acute lymphocytic leukemia, squamous cell cancer, american society of hematology, radiation oncology, pediatric oncology, american society of clinical oncology, cancer news, prostate cancer, colon cancer, ovarian cancer, cervical cancer, neoplasm, immunosuppression, kaposi's sarcoma, malignancy, mammography, bone marrow transplantation, tamoxifen, leucovorin, 5-FU, carboplatin, stem cell, mutation, genetic, oncogenic, carcinogenic, 5 year survival, stage, progression, metastatic, radical, prostatectomy, end of life, pain control

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Endoscopic Sphincterotomy and Long-Term Risk of Cholangiocarcinoma
Journal of the National Cancer Institute, 05/14/08

Email This Article

Save in My Library

Free Abstract

Mortensen FV et al. - The gradual decrease in cholangiocarcinoma rate over time after ERC for sphincterotomy patients indicates that some of these patients had a cholangiocarcinoma that was present at the time of ERC but not diagnosed until 2–5 years later.

Sponsor

--- HEPATOBILIARY/PANCREAS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Quality-of-Life Assessment for Routine Oncology Clinical Practice
The Journal of Supportive Oncology, 06/16/08

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study
The Lancet, 06/24/08

Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma
World Journal of Gastroenterology, 07/14/08

...All of Hepatobiliary/Pancreas